RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Qsam Biosciences Stock

Qsam Biosciences Market capitalization 2024

Qsam Biosciences Market capitalization

14.63 M USD

Ticker

QSAM

ISIN

US74738N1037

WKN

A2QERD

In 2024, Qsam Biosciences's market cap stood at 14.63 M USD, a 261.79% increase from the 4.04 M USD market cap in the previous year.

The Qsam Biosciences Market capitalization history

YEARMarket Capitalization (undefined USD)
202214.63
20210.4
20200.05
2019-
2018-
2017-
2016-
2015-

Qsam Biosciences Aktienanalyse

What does Qsam Biosciences do?

Qsam Biosciences Inc. is a pharmaceutical and biotechnology company specializing in the development and marketing of innovative medicines and diagnostics. The company was founded in 2004 by a group of scientists with the goal of developing innovative and effective therapies for various diseases. The business model of Qsam Biosciences is based on close collaboration between experts in molecular biology, biochemistry, biophysics, and pharmacology. State-of-the-art technologies and methods are used to explore new drugs, characterize their pharmacological effects, and test their efficacy and safety in rigorous clinical trials. A particular focus is on the development of therapies for cancer, autoimmune diseases, and neurodegenerative diseases such as Alzheimer's and Parkinson's. Qsam Biosciences already has promising candidates in its pipeline, which are being tested in phase 2 and phase 3 studies. In addition to developing new drugs, Qsam Biosciences also operates a diagnostics division that focuses on developing new test methods for early detection of diseases. Molecular diagnostic methods are particularly used to detect diseases such as cancer, cardiovascular diseases, and infectious diseases at an early stage. Among Qsam Biosciences' key products are a range of antibodies and protein inhibitors that specifically target disease-specific targets, demonstrating high efficacy and precision. These drugs are used both as monotherapy and in combination with other medications to ensure optimal treatment. One particular highlight is the drug QB-101, currently being developed for the treatment of Parkinson's disease. QB-101 is a novel protein inhibitor that specifically inhibits the activity of dopamine-degrading enzymes, reducing dopamine breakdown in the brain. QB-101 has already shown promising results in clinical trials and is currently being tested in a large phase 2 study. Overall, Qsam Biosciences is an innovative and dynamic company that makes a significant contribution to the fight against serious diseases with its products and services. With the use of state-of-the-art technologies and methods, as well as close collaboration between experts from different disciplines, Qsam Biosciences is well positioned to develop effective medicines and diagnostics that can improve and prolong patients' lives. Qsam Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Qsam Biosciences's Market Capitalization

Qsam Biosciences's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Qsam Biosciences's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Qsam Biosciences's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Qsam Biosciences’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Qsam Biosciences stock

What is the current Qsam Biosciences market capitalization?

The current market capitalization of Qsam Biosciences is 14.63 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Qsam Biosciences.

How has the market capitalization of Qsam Biosciences developed in recent years?

The market capitalization of Qsam Biosciences has increased/decreased by 261.79% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Qsam Biosciences?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Qsam Biosciences?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Qsam Biosciences have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Qsam Biosciences pay?

Over the past 12 months, Qsam Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Qsam Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Qsam Biosciences?

The current dividend yield of Qsam Biosciences is .

When does Qsam Biosciences pay dividends?

Qsam Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Qsam Biosciences?

Qsam Biosciences paid dividends every year for the past 0 years.

What is the dividend of Qsam Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Qsam Biosciences located?

Qsam Biosciences is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Qsam Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Qsam Biosciences from 11/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/12/2024.

When did Qsam Biosciences pay the last dividend?

The last dividend was paid out on 11/12/2024.

What was the dividend of Qsam Biosciences in the year 2023?

In the year 2023, Qsam Biosciences distributed 0 USD as dividends.

In which currency does Qsam Biosciences pay out the dividend?

The dividends of Qsam Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Qsam Biosciences

Our stock analysis for Qsam Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qsam Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.